0001203311-17-000028.txt : 20170602 0001203311-17-000028.hdr.sgml : 20170602 20170602190832 ACCESSION NUMBER: 0001203311-17-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170531 FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIMES VAUGHN B CENTRAL INDEX KEY: 0001361966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 17889558 MAIL ADDRESS: STREET 1: C/O SEATTLE GENETICS, INC. STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-05-31 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001361966 HIMES VAUGHN B 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Technical Officer Common Stock 2017-05-31 4 M 0 600 9.23 A 151883 D Common Stock 2017-05-31 4 S 0 600 63.41 D 151283 D Common Stock 2017-05-31 4 M 0 9400 9.23 A 160683 D Common Stock 2017-05-31 4 S 0 9400 62.54 D 151283 D Non-Qualified Stock Option (right to buy) 9.23 2017-05-31 4 M 0 600 0.0 D 2019-04-30 Common Stock 600 12564 D Non-Qualified Stock Option (right to buy) 9.23 2017-05-31 4 M 0 9400 0.0 D 2019-04-30 Common Stock 9400 3164 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $63.26 to $63.57. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.00 to $62.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Shares vested at a rate of 25% on 4/30/2010 and monthly thereafter until all the shares were fully vested on 4/30/2013. /s/ Jean Liu 2017-06-02